Clinical Trial

Transcranial Magnetic Stimulation (TMS) in the Treatment of Anorexia Nervosa

Terminated
View on ClinicalTrials.gov →
Why the trial stopped
Study funding ended prior to completing the study enrollment.
Summary
Anorexia nervosa is a severe psychiatric disorder associated with food avoidance and body image distortion, that is feeling fat despite being underweight. It is the third most common chronic illness among adolescent females, and its mortality reaches its peak between the ages 16 and 29 years old. There are very few treatments for anorexia nervosa and especially no biological treatments have been approved. Recent brain imaging research has repeatedly implicated brain circuits that include the insula in the disorder. The insula is a brain region important in taste processing as well as in the integration of body perception and has strong connections to the brain reward system. Transcranial magnetic stimulation (TMS) is a relatively new methodology that has been shown to alter neurocircuitry and alleviate depression. Here, the study goal is to develop TMS as a methodology to change altered neurocircuitry in anorexia nervosa and alleviate disorder specific behaviors.
Protocol Amendment History 5 changes
critical Trial terminated 2026-08-04
critical Trial terminated: Study funding ended prior to completing the study enrollment. 2026-08-04
notable Enrollment reduced: 40 -> 10 participants 2026-08-04
notable Primary completion moved earlier: 2026-10-01 -> 2026-03-11 2026-08-04
minor Completion moved earlier: 2026-10-01 -> 2026-03-11 2026-08-04
Trial Details
NCT Number NCT05368844
Lead Sponsor University of California, San Diego
Conditions Anorexia Nervosa
Enrollment 10 participants
Start Date 2022-06-16
Primary Completion 2026-03-11 (estimated)
Study Completion 2026-03-11 (estimated)
Updated on ClinicalTrials.gov 2026-08-03